6. Booked case
Regular visits
3 Ultrasound scans done, all normal.
Tetanus vaccination done
On supplementary multivitamins
No history of GDM ,PIH ,Infection or any rash during pregnancy .
Birth history
Antenatal history:
8. Baby was cyanosed at birth
Suctioning and PPV done, baby revived
Admitted in NICU, for respiratory distress
Feeding not started due to respiratory distress
Post natal history
9. Family History
8th issue of non consangious marriage , other siblings
are alive and healthy
Socioeconomic hx.
father is labourer , 9 family members live in rented
house
10. sick looking tachypenic baby lying in incubator with respiratory
distress and obvious subcostal and intercostal recessions.
Vitals :
SPO2 = 94% (on bubble cpap 3/3)
R/R = 76 breaths/mint
H/R = 155 beats/mint
Temp = Afebrile
Pre ductal and post ductal 02 saturation . ( 94%)
A-, J-, C-, D-, Ed-
General Physical Examination
12. HEAD: Anterior fontanelle was wide
and flat
EYES: Normal
NOSE: nasal flaring
MOUTH & PALATE: No cleft lip and palate
EARS: Normally placed, No deformation
LIMBS: Normal
NAILS: MECONIUM STAINED
BACK: Normal
UMBLICUS: MECONIUM STAINED
(YELLOW GREEN COLOR)
Genitals : normal male
HEAD TO TOE EXAMINATION
13. INSPECTION:
Shape of the chest is
symmetrical with no deformities
Equal chest movement on both
sides with subcostal and
intercostal recessions.
PALPATION:
Trachea central placed
Apex beat lies at 4th left
intercostal space – mid-clavicular
line
AUSCULTATION:
Bilateral crepts
Equal Bilateral air entry
14. INSPECTION: non distended
No scar or distended veins
Umbilical cord centrally placed
PALPATION:
Soft, non-tender with no visceromegaly
AUSCULTAION:
Gut sounds audible
Abdomen
15. INSPECTION:
Normal shape of precordium with no visible pulsation.
PALPATION:
Apex beat palpable in left 4th intercoastal space slightly medial to mid clavicular line.
AUSCULTATION:
Both S1 and S2 were audible with no added sounds.
CVS Examination
16. REFLEXES:
MORO: Incomplete
SUCKING: Fair
ROOTING: good
GRASPING: Good
ACTIVTY:
Good
TONE:
Normal
CNS Examination
26. Baby kept on bubble cpap for 3 days
respiratory distress improved
OG feed started
CPAP Tapered
Plan shift to Tr on mother feed
Course of illness
44. DEFINITION
Meconium aspiration syndrome (MAS) is a
respiratory disorder caused by inhalation of amniotic
fluid contaminated with meconium into the
tracheobronchial tree.
46. P
H
Y
S
I
O
L
O
G
Y
• Ph of meconium- 5.5 to 7.0
• Sterile, viscous, dark green, odourless substance
•COMPONENTS-
Water(72-80%),
Desquamated cells
Mucin, lanugo hair
Amniotic fluid & intestinal secretion
Blood group specific glycoprotein/ bile pigments
47. • Meconium is 1st found in fetal ileum between 10-
16th week of gestation
• In utero passage of meconium is uncommon due to
Lack of strong peristalsis
Good anal sphincter tone
A cap of viscous meconium in the rectum
• Meconium passage uncommon < 34weeks
48. •Watery-
amniotic fluid that is thinly stained
•Moderately stained-
opaque fluid without particle
•Pea soup-
fluid with thick meconium & particle
49. E
F
F
E
C
T
SO
FMECONIUM
• Directly alters the amniotic fluid antibacterial activity
increase infection
erythema toxicum
• Irritant to fetal skin -------
• Meconium aspiration
51. R
I
S
KF
A
C
T
O
R
S
• Maternal hypertension/DM
• Maternal chronic respiratory/cardiovascular disease
• Heavy cigarette smoking
• Post date pregnancy
• Pre-eclampsia/eclampsia
• Oligohydramnios
• Chorioamnionitis
• Abnormal fetal heart pattern
53. AIRWAY OBSTRUCTION
COMPLETE PARTIAL
Atelectasis ball valve effect
CHEMICAL PNEUMONITIS –
• Enzymes, bile salts, FFA irritate the airway/ parenchyma
• Release of cytokines( IL1B, IL8, TNF )
• Direct lung damage/ vascular permeability
54. SURFACTANT DYSFUNCTION
• Damage to type 2 alveolar cells ------ surfactant proteinA&B
• Protein / FFA in meconium cause alteration in the phospholipid
structure of surfactant ----- ability to reduce surface tension
55. + persistent hypoxia /acidosis
Remodelling of pulmonary vasculature PPHN (1/3rd
cases of MAS )
Fetal compromise + inflammatory
mediators
56.
57. H
I
S
T
O
R
Y
• Presence of meconium in amniotic fluid is required to
cause MAS
• Green urine may be observed in newborns with MAS less
than 24 hours of birth. Meconium pigments can be
absorbed by lungs & excreted in urine.
• Term/post term
• Depressed at birth
58. D
E
LI
V
E
R
YR
O
O
M
• Infants with MSAF present with poor muscle tone & breathing
efforts ----- initial steps done under radiant warmer
• PPV ------ not breathing/ HR<100
• Routine intubation for tracheal suctioning is no longer
suggested.
• Skilled personal in intubation needed during delivery.
• If infant does not improve with PPV/ intubation then go for
tracheal suctioning.
59. PH
Y
S
I
C
A
LEXAMINATION
• EVIDENCE OF POST MATURITY: Peeling skin, long
fingernails, and decreased vernix.
• Nails will become stained after 6 hours and vernix after
12 to 14 hours of exposure .
• Umbilical cord staining
60. • Present at birth
• Initial apnea respiratory distress
• Tachypnea , marked cyanosis
• Use of accessory muscles of respiration
• Barrel shaped chest
• Crepts/wheeze
• Sign of cerebral irritation from cerebral edema or hypoxia
: jitteriness, seizures
61. CLASSIFICATIONO
FR
E
S
P
I
R
A
T
O
R
YD
I
S
T
R
E
S
S
• MILD MAS –
Disease requiring <40% o2 for <48hours
• MODERATE MAS-
Disease requiring >40% o2 for >48 hours without air leak
• SEVERE MAS-
Disease requiring assisted ventilation for >48 hours often
associated with PPHN
62. DIA
G
N
O
S
I
S
• MAS must be considered in any infant born through
MSAF who develops symptoms of RD with typical chest
Xray finding
• A chest radiographs - hyperinflation of the lung field and
flatten diaphragms
• Coarse irregular patchy infiltrates
• A pneumothorax and pneumomediastinum may be
present
63.
64. left lung demonstrating
the streaky lucencies of
the air in the interstitium
(red arrows)
complicated by by a
pneumothorax
( yellow arrow )
65. • Arterial blood gas measurements typically show hypoxemia
and hypercarbia.
• Infants with pulmonary hypertension and right-to-left
shunting may have a gradient right-to-left shunting may
have a gradient in oxygenation between preductal and
postductal samples.
• Echocardiogram for evaluation of PPHN.
66. M
A
N
A
G
E
M
E
N
T
• Monitor the respiratory distress/ O2 saturation
• Optimal thermoneutral environment
• Minimal handling
• Blood glucose/ calcium monitoring
• ABG in severely depressed babies
• Circulatory support ----- NS/ inotropes/ PRBC
• Avoid chest physiotherapy
67. •OXYGEN THERAPY- for hypoxemia.
Serial monitoring of blood gases/ PH
If FiO2 >0.40
trial of CPAP ( caution : air trapping/ hyperinflation)
severe RD, PaC02 >60mm of Hg/ PaO2 <50mm of Hg
Mechanical ventilation
68. • High inspiratory pressure (30-35cm of water)
• Short inspiratory time
• Adequate expiratory time to prevent air trapping
• Low PEEP- 4-5 cm of water ---- splinting partially obstructed
airway & equalizing V/Q mismatch.
• Inspiratory time- 0.4-0.5sec.
69. • Severe MAS – high frequency ventilation with jet or
oscillatory ventilator.
It reduces barotrauma and air leak syndrome.
• ECMO- for infants with refractory respiratory failure.
survival rate >94% & reduces the duration of
mechanical ventilation
70. • ANTIBIOTICS:
Indicated if infiltrate on chest Xray
Broad spectrum antibiotics
Blood c/s – determine the duration
• CORTICOSTEROID:
Not routinely used
Reduce meconium induced inflammation & PG mediated
pulmonary vasoconstriction
Improves oxygenation and decreases length of NICU stay
72. Decrease length of NICU stay, improve
Oxygenation
• SEDATIVE – Mechanical ventilation
• ANTIOXIDANTS – N acetylcysteine
• Inhalational NO for PPHN
reduces the need of ECMO
73. P
R
E
V
E
N
T
I
O
NO
F
M
A
S
• Careful monitoring during pregnancy
• AMNIOINFUSION - For treatment of variable fetal HR
deceleration by relieving umbilical cord compression.
• TIME OF DELIVERY- induce as early as 41weeks
• MODE OF DELIVERY- not significant.
74. C
O
M
P
L
I
C
A
T
I
O
N
S
•AIR LEAK – Pneumothorax & pneumomediastinum – 15 to 33%.
More with mechanical ventilation due to air trapping
• PPHN
• PULMONARY SEQUELAE- 5% require supplemental O2 at
1month .
Airway reactivity, higher incidence of pneumonia & abnormal
pulmonary function.